Acesso livre
Acesso livre

Medicina de Emergências

Quando iniciar vasopressina no choque séptico: estratégia proposta.

20 Mai, 2022 | 13:23h

When to start vasopressin in septic shock: the strategy we propose – Critical Care

Diretriz AHA/ASA | Tratamento de pacientes com hemorragia cerebral espontânea.

19 Mai, 2022 | 13:24h

2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association – Stroke

Tópicos principais a saber: 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage – American Heart Association

Comunicado de imprensa: New guideline refines care for brain bleeds: compression socks, some meds not effective – American Heart Association

 

Comentário no Twitter

 

Tratamento das interações medicamentosas com nirmatrelvir/ritonavir (Paxlovid).

19 Mai, 2022 | 13:08h

Management of Drug Interactions With Nirmatrelvir/Ritonavir (Paxlovid®): Resource for Clinicians – Infectious Diseases Society of America

Comentário: IDSA offers guidance on managing drug interactions with nirmatrelvir/ritonavir – ACP Internist

Conteúdos relacionados:

Paxlovid’s failure as a preventative measure raises questions, but doctors still back it as a therapeutic – STAT

Yes, Relapses After Paxlovid Happen — Now What? – HIV and ID Observations

Covid-19: What is the evidence for the antiviral Paxlovid? – The BMJ

Yes, Relapses After Paxlovid Happen — Now What? – HIV and ID Observations

WHO recommends highly successful COVID-19 therapy and calls for wide geographical distribution and transparency from originator – World Health Organization

A living WHO guideline on drugs for covid-19 – The BMJ

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 – New England Journal of Medicine

Prescribing Nirmatrelvir–Ritonavir: How to Recognize and Manage Drug–Drug Interactions – Annals of Internal Medicine

The COVID-19 Treatment Guidelines Panel’s Statement on Potential Drug-Drug Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Concomitant Medications – NIH COVID-19 Treatment Guidelines Panel

Estudo de coorte | Exclusão rápida da lesão aguda de miocárdio e infarto com uma troponina cardíaca T de alta sensibilidade no departamento de emergência.

19 Mai, 2022 | 12:48h

Rapid Exclusion of Acute Myocardial Injury and Infarction with a Single High Sensitivity Cardiac Troponin T in the Emergency Department: a Multicenter United States Evaluation – Circulation (link para o resumo – $ para o texto completo)

Comentário: Higher Single-Sample hs-cTnT Threshold Can Safely Exclude MI – TCTMD

Sinopse de diretriz | Terapia antitrombótica para tromboembolismo venoso.

18 Mai, 2022 | 17:04h

Antithrombotic Therapy for Venous Thromboembolism – JAMA (gratuito por tempo limitado)

Diretriz original: Antithrombotic Therapy for VTE Disease

Second Update of the CHEST Guideline and Expert Panel Report

Atualização clínica da COVID-19 para o médico emergencista: parada cardíaca dentro e fora do ambiente hospitalar.

18 Mai, 2022 | 17:01h

Clinical update on COVID-19 for the emergency clinician: Cardiac arrest in the out-of-hospital and in-hospital settings – The American Journal of Emergency Medicine

Conteúdos relacionados:

Clinical update on COVID-19 for the emergency and critical care clinician: Medical management – American Journal of Emergency Medicine

Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation – The American Journal of Emergency Medicine

Estudo RECOVERY | Por questões de segurança, o recrutamento de pacientes com Covid-19 apresentando hipóxia sem oxigênio ou recebendo oxigênio simples para doses mais altas de corticosteroides foi encerrado.

18 Mai, 2022 | 17:00h

Recruitment to higher dose corticosteroids closed for patients with hypoxia on no oxygen or receiving simple oxygen – University of Oxford

Estudo de coorte | Trombose venosa ou arterial e mortes em casos de COVID-19.

18 Mai, 2022 | 16:58h

Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study – The Lancet Infectious Diseases

Comentário convidado: Risk of arterial and venous thromboses after COVID-19 – The Lancet Infectious Diseases

Comunicado de imprensa: COVID-19’s high blood clot risk – University of Oxford

 

Comentário no Twitter

Sob licença de Creative Commons Attribution (CC BY 4.0)

Estudo de coorte | Risco de morte e reinternação não planejada após alta hospitalar de internação por COVID-19.

18 Mai, 2022 | 16:56h

The risk of death or unplanned readmission after discharge from a COVID-19 hospitalization in Alberta and Ontario – Canadian Medical Association Journal

Comentário: Study: Readmission rate for COVID-19 is 11% – CIDRAP

Estudo de coorte | Sustentabilidade de uma intervenção de apoio a decisão clínica voltada para estimular o cuidado ambulatorial de pacientes selecionados com embolia pulmonar aguda.

18 Mai, 2022 | 16:45h

Sustainability of a Clinical Decision Support Intervention for Outpatient Care for Emergency Department Patients With Acute Pulmonary Embolism – JAMA Network Open

Conteúdo relacionado: Outpatient versus inpatient treatment for acute pulmonary embolism – Cochrane Library

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.